Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/1996
08/29/1996CA2212846A1 Prostate-specific membrane antigen and uses thereof
08/29/1996CA2211995A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
08/29/1996CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/28/1996EP0728215A1 METHOD OF BINDING MATERIAL TO THE $g(b)-AMYLOID PEPTIDE
08/28/1996EP0728214A1 Stable cell lines capable of expressing the adeno-associated virus replication gene
08/28/1996EP0728208A1 Tomato xyloglucan endo-transglycosylase
08/28/1996EP0728201A1 Brain-derived membrane-associated crf binding proteins
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728196A1 Mutants of a thermostable neutral protease from bacillus
08/28/1996EP0728191A1 A secretion sequence for the production of a heterologous protein in yeast
08/28/1996EP0728147A1 Receptor specific atrial natriuretic peptides
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728142A1 Novel antler-derived bone growth factors
08/28/1996EP0728141A1 A method for identifying anti-parasitic compounds
08/28/1996EP0728023A1 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells
08/28/1996EP0728015A1 Combinatorial polypeptide antigens
08/28/1996EP0728011A1 Growth factor compositions, preparation and use
08/28/1996EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family
08/28/1996EP0533942B1 Process for expressing polypeptide
08/28/1996EP0406297B1 Medical use of neuropeptide Antagonist G
08/28/1996EP0313578B1 Novel osteoinductive compositions
08/28/1996CN1129984A Immunoassay for soluble fibrin polymers
08/28/1996CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity
08/28/1996CN1129953A Synthesis of saccharic composition
08/28/1996CN1129737A Modified protein for gene transfer and process for producing the same
08/27/1996US5550228 Vectors; transformed microorganisms and protoplasts; plant cells
08/27/1996US5550223 Lipoprotein I (ompi) of pseudomonas aeruginosa
08/27/1996US5550221 Genetic engineering
08/27/1996US5550216 Gelatinase A inhibitor, and analytical reagent thereof for the determination of gelatinase A
08/27/1996US5550052 Useful for detection of lav antibodies in human sera
08/27/1996US5550049 Useful as insecticides and arachnicidic agents
08/27/1996US5550045 Efficient production of enzyme useful for degrading pectin
08/27/1996US5550038 Molecular farming
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025520A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
08/22/1996WO1996025498A2 Mpl ligand analogs
08/22/1996WO1996025497A1 New chemokines expressed in pancreas
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
08/22/1996WO1996025489A1 Psychrophilic protease and psychrophilic bacteria
08/22/1996WO1996025487A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE
08/22/1996WO1996025432A1 Human g-protein coupled receptor
08/22/1996WO1996025428A1 Novel nk374186 analogues or pharmacologically acceptable salts thereof
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025175A1 ADMINISTRATION OF A CYCLOSPORINE-SPECIFIC MONOCLONAL ANTIBODY THAT CROSS-REACTS WITH HIV-1 p24 GAG TO TREAT HIV INFECTION
08/22/1996WO1996025041A1 Insecticidal peptides from spider venom
08/22/1996WO1996019498A3 T cell stimulating protein of pestivirus
08/22/1996WO1996017941A3 Production of c-terminal amidated peptides from recombinant protein constructs
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996WO1996015149A3 Methods and compositions for screening for presynaptic calcium channel blockers
08/22/1996DE19605657A1 Proinsulinderivat und Verfahren zur Herstellung von menschlichem Insulin Proinsulin derivative and process for the preparation of human insulin
08/22/1996CA2213443A1 Insecticidal peptides from spider venom
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213132A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211938A1 Psychrophilic protease and psychrophilic bacteria
08/22/1996CA2211101A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/21/1996EP0727486A2 Tumour suppressor gene
08/21/1996EP0727436A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727435A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0726957A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726953A1 Human kunitz-type protease inhibitors
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726951A1 Manufacture and use of polypeptides tagged using binding molecules
08/21/1996EP0726949A1 Opioid receptor: compositions and methods
08/21/1996EP0726946A1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS
08/21/1996EP0726945A1 B1k CHAIN OF LAMININ AND METHODS OF USE
08/21/1996EP0726944A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
08/21/1996EP0726942A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
08/21/1996EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use
08/21/1996EP0726912A1 Cd6 ligand
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0441886B1 Expression and processing of acetylated fgf's in yeast
08/21/1996CN1129460A Epstein-barr virus dna sequences encoding diagnostically relevant virus capid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic
08/21/1996CN1129255A Method for making recombined granular macrophage colony stimulating factor of human body
08/20/1996US5547940 Using a polypeptide
08/20/1996US5547934 A polypeptide which acts as a fungicide and a protozoicide
08/20/1996US5547871 Genetic engineering
08/20/1996US5547867 Cultivating host cell under controlled ph and temperature conditions
08/20/1996US5547856 Hepatocyte growth factor variants
08/20/1996US5547855 Kainate-binding human CNS glutamate receptors EAA3C and EAA3D, DNA encoding them, and expression of the DNA in transformed cells
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547852 Composition containing the P40 subunit of interleukin-12
08/20/1996US5547846 Immunogenic regions on the E7 protein of human papillomavirus type 16
08/20/1996US5547670 Polypeptides
08/15/1996WO1996024848A1 Monoclonal antibodies for human osteogenic cell surface antigens
08/15/1996WO1996024678A1 Process for the production of proteins
08/15/1996WO1996024676A1 Bioactive fusion proteins and pre-existing tumor therapy
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS